Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Lyssikatos Joseph P has filed 10 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Feb 17, 2026.
On the most recent filing, Lyssikatos Joseph P is listed as CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc. Inside the rolling window, Lyssikatos Joseph P reported no open-market purchases and 8 open-market sales totaling $4.9M in ELVN. The largest disclosed transaction in the window is a sale of 91,198 ELVN shares on Jan 9, 2026, worth $2.5M.
Companies traded
Other insiders at ELVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $145K | Feb 10 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 20,000 | $535K | Jan 22 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 41,302 | $993K | Jan 12 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 91,198 | $2.5M | Jan 12 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $84K | Dec 23 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $279K | Nov 21 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $276K | Oct 22 | SEC ↗ | |
| ELVN | CHIEF SCIENTIFIC OFFICER | Sale | 4,000 | $81K | Sep 30 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Lyssikatos Joseph P made?
Lyssikatos Joseph P has filed 10 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Lyssikatos Joseph P trade?
Lyssikatos Joseph P has filed SEC Form 4 disclosures for 1 company, including ELVN.
When was Lyssikatos Joseph P's most recent SEC Form 4 filing?
Lyssikatos Joseph P's most recent SEC Form 4 filing on Tracefour is dated Feb 17, 2026.
What is Lyssikatos Joseph P's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lyssikatos Joseph P is listed as CHIEF SCIENTIFIC OFFICER.
What is Lyssikatos Joseph P's total buy and sell value in the current window?
Inside the rolling retention window, Lyssikatos Joseph P bought $0 and sold $4.9M based on SEC Form 4 filings.
What was Lyssikatos Joseph P's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 91,198 ELVN shares on 2026-01-09, worth $2.5M, per SEC Form 4 filings.